当前位置:首页 - 行情中心 - 艾迪药业(688488) - 财务分析 - 现金流量表

艾迪药业

(688488)

  

流通市值:72.37亿  总市值:72.37亿
流通股本:4.21亿   总股本:4.21亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金337,709,529.25174,325,396.22504,266,356.01364,549,217.78
  收到的税费返还--3,643,027.613,643,027.61
  收到其他与经营活动有关的现金71,758,605.3975,317,634.7489,773,697.2626,250,012.03
  经营活动现金流入小计409,468,134.64249,643,030.96597,683,080.88394,442,257.42
  购买商品、接受劳务支付的现金66,713,327.0826,974,782.03220,069,821.59160,520,761.5
  支付给职工以及为职工支付的现金78,264,424.2944,032,775.47115,392,755.0193,602,832.63
  支付的各项税费37,611,921.7816,957,341.7626,513,413.4511,167,435.76
  支付其他与经营活动有关的现金202,430,065.28121,923,961.08273,204,880.62130,078,903.26
  经营活动现金流出小计385,019,738.43209,888,860.34635,180,870.67395,369,933.15
  经营活动产生的现金流量净额24,448,396.2139,754,170.62-37,497,789.79-927,675.73
二、投资活动产生的现金流量:
  取得投资收益收到的现金697,756.63411,961.734,192,094.183,870,813.45
  处置固定资产、无形资产和其他长期资产收回的现金净额--120,963.141,789.92
  收到的其他与投资活动有关的现金199,400,000106,000,000836,346,510.55681,356,510.55
  投资活动现金流入小计200,097,756.63106,411,961.73840,659,567.87685,229,113.92
  购建固定资产、无形资产和其他长期资产支付的现金16,599,571.6110,535,646.2144,561,428.6348,154,317.85
  投资支付的现金1,750,0001,750,000--
  取得子公司及其他营业单位支付的现金5,040,000---
  支付其他与投资活动有关的现金185,000,00030,000,000711,000,000585,150,000
  投资活动现金流出小计208,389,571.6142,285,646.21755,561,428.63633,304,317.85
  投资活动产生的现金流量净额-8,291,814.9864,126,315.5285,098,139.2451,924,796.07
三、筹资活动产生的现金流量:
  取得借款收到的现金312,024,000200,000,000410,868,000348,968,000
  筹资活动现金流入小计312,024,000200,000,000410,868,000348,968,000
  偿还债务支付的现金266,012,000204,962,000336,400,000280,450,000
  分配股利、利润或偿付利息支付的现金12,726,499.594,198,189.5515,852,126.4410,977,317.24
  支付其他与筹资活动有关的现金1,833,676.091,357,256.613,752,967.482,357,018.54
  筹资活动现金流出小计280,572,175.68210,517,446.16356,005,093.92293,784,335.78
  筹资活动产生的现金流量净额31,451,824.32-10,517,446.1654,862,906.0855,183,664.22
四、汇率变动对现金及现金等价物的影响-8,346.65444.4-6,588.77-76,638.41
五、现金及现金等价物净增加额47,600,058.993,363,484.38102,456,666.76106,104,146.15
  加:期初现金及现金等价物余额324,259,532.77324,259,532.77221,802,866.01221,802,866.01
  期末现金及现金等价物余额371,859,591.67417,623,017.15324,259,532.77327,907,012.16
补充资料:
  净利润26,489,470.65--138,835,089.7-
  资产减值准备2,896,425.23-65,199,313.37-
  固定资产和投资性房地产折旧16,952,447.15-33,197,184.19-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧16,952,447.15-33,197,184.19-
  无形资产摊销9,461,335.39-14,696,691.6-
  长期待摊费用摊销2,501,848.84-3,530,890.53-
  处置固定资产、无形资产和其他长期资产的损失-99,170.37---
  固定资产报废损失137,770.56-431,561.44-
  公允价值变动损失-14,218,294.32--10,763,010.03-
  财务费用8,096,590.56-15,360,254.21-
  投资损失568,771.59--6,962,716.68-
  递延所得税1,201,361.07--29,081,563.23-
  其中:递延所得税资产减少-167,758.08--24,762,435.4-
    递延所得税负债增加1,369,119.15--4,319,127.83-
  存货的减少-14,315,826.18--44,277,491.41-
  经营性应收项目的减少-11,736,449.13-76,977,305.96-
  经营性应付项目的增加-4,162,332.96--14,342,956.61-
  其他-482,055.71--5,314,820.51-
  现金的期末余额371,859,591.67-324,259,532.77-
  减:现金的期初余额324,259,532.77-221,802,866.01-
  现金及现金等价物的净增加额47,600,058.9-102,456,666.76-
公告日期2025-08-292025-04-302025-04-302024-10-31
审计意见(境内)标准无保留意见
TOP↑